Vaccines - Tanzania | Statista Market Forecast

The Vaccines market in Tanzania is anticipated to witness a substantial growth in revenue, with projections indicating that it will reach US$17.32m by the year 2024.
Furthermore, it is expected to display a promising annual growth rate (CAGR 2024-2029) of 2.48%, ultimately leading to a market volume of US$19.57m by 2029.
In terms of global comparison, United States is forecasted to generate the highest revenue in the Vaccines market, amounting to a staggering US$29.12bn in 2024.
Tanzania has seen an increase in demand for vaccines, driven by a growing awareness of the importance of immunization in preventing diseases.

Definition:
This market covers vaccines against infectious diseases. They help to prevent diseases, usually through active immunization. Vaccines against infectious diseases transmitted by viruses (e.g., hepatitis A and B or COVID-19) and bacteria (e.g., typhoid fever or meningococcus) are included.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Pfizer, GlaxoSmithKline, Merck & Co, Sanofi, Moderna, AstraZeneca

Vaccines against infectious diseases
Prophylactic and therapeutic vaccines
Flu vaccines
COVID-19 vaccines

Sera and gammaglobulins
Antivirals
Antibiotics

The Tanzanian Vaccines market is developing at a steady pace due to various customer preferences and local special circumstances.

Customer preferences: There is a growing demand for vaccines in Tanzania due to the increasing awareness about the importance of immunization. Customers are becoming more conscious of the need to protect themselves and their families from preventable diseases. The government is also actively promoting vaccination campaigns to increase the uptake of vaccines. Additionally, the rise in the incidence of infectious diseases such as malaria, HIV/AIDS, and tuberculosis is driving the demand for vaccines.

Trends in the market: The Tanzanian vaccines market is witnessing a shift towards more advanced and innovative vaccines. There is an increasing demand for combination vaccines that offer protection against multiple diseases. This trend is driven by the need to reduce the number of injections required for vaccination. There is also a growing demand for vaccines that are more effective and have fewer side effects. In addition, there is a trend towards the development of vaccines that can be stored at higher temperatures, which is particularly relevant for countries with limited access to refrigeration facilities.

Local special circumstances: Tanzania has a large rural population, which poses unique challenges for the distribution and delivery of vaccines. The country has a weak healthcare infrastructure, which makes it difficult to reach remote areas. This has led to the development of innovative delivery models such as mobile clinics and outreach programs. Additionally, Tanzania has a high burden of infectious diseases, which has led to the development of vaccines that are specifically targeted towards these diseases.

Underlying macroeconomic factors: Tanzania has a growing economy, which is driving the demand for vaccines. The country has a young and growing population, which is expected to drive the demand for vaccines in the future. The government is also investing in the healthcare sector, which is expected to boost the development and distribution of vaccines. However, the country still faces challenges such as limited access to healthcare facilities in rural areas, which could hinder the growth of the vaccines market.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

As of March 2023, more than 13 billion COVID-19 vaccine doses had been administered worldwide. Wide-spread vaccine availability, increasing herd immunity, and lower case numbers led to renewed hope and a feeling of normality in 2023. However, especially during the winter seasons and with the potential emergence of new variants of the virus (like Omicron in 2021-2022), tracking of coronavirus cases repeatedly becomes a focus for the public. Thus, there is a level of uncertainty about what developments the winter season 2023/2024 might bring.